Screener
Gyre Therapeutics, Inc. GYRE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s short-term investments?
- Gyre Therapeutics, Inc. (GYRE) reported short-term investments of $14.06M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s short-term investments changed year-over-year?
- Gyre Therapeutics, Inc.'s short-term investments decreased by 21.3% year-over-year, from $17.87M to $14.06M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s short-term investments?
- Over 3 years (2020 to 2025), Gyre Therapeutics, Inc.'s short-term investments has grown at a -32.1% compound annual growth rate (CAGR), from $48.99M to $15.36M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Gyre Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude